Anthracycline analogs: re-assessments and prospects.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D004317:Doxorubicin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D004341:Drug Evaluation; D006027:Glycosides / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D009279:Naphthacenes / Q000009:adverse effects / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D006027:Glycosides; D009279:Naphthacenes; D004317:Doxorubicin